Overview

Effects of SH T00658ID on Libido

Status:
Completed

Trial end date:
2010-07-01

Target enrollment:

Participant gender:

Summary

The aim of the study is to investigate whether women on oral contraceptives (OCs) suffering from acquired OC-associated female sexual dysfunction (FSD) for at least 3 months but no longer than one year will express the same level of sexual distress when taking SH T00658ID compared to Microgynon, the usual OC prescribed for women with OC-associated FSD.

Phase:

Phase 3

Details

Lead Sponsor:

Bayer

Treatments:

Contraceptive Agents
Contraceptives, Oral
Dienogest
Estradiol
Estradiol 17 beta-cypionate
Estradiol 3-benzoate
Estradiol valerate
Ethinyl Estradiol
Ethinyl Estradiol-Norgestrel Combination
Ethinyl estradiol, levonorgestrel drug combination
Levonorgestrel
Polyestradiol phosphate